Cargando…
Response to a Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
Autores principales: | Zhao, Peng, Sun, Tian, Lyu, Cheng, Du, Yanan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265037/ https://www.ncbi.nlm.nih.gov/pubmed/37119442 http://dx.doi.org/10.1002/advs.202301330 |
Ejemplares similares
-
Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis
por: Zhao, Peng, et al.
Publicado: (2022) -
Comment on “Scar‐Degrading Endothelial Cells as a Treatment for Advanced Liver Fibrosis”
por: Dolivo, David M., et al.
Publicado: (2023) -
Advanced Liver Fibrosis Is Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2022;46:630-9)
por: Seo, Da Hea, et al.
Publicado: (2022) -
Reply to Chemical Risk Factors of Primary Liver Cancer: A Short Comment [Response To Letter]
por: Barsouk, Adam, et al.
Publicado: (2021) -
Response to Comment on: “Cardiovascular adverse events in patients with chronic lymphocytic leukemia receiving acalabrutinib monotherapy: pooled analysis of 762 patients”
por: Brown, Jennifer R.
Publicado: (2021)